DK1691833T3 - Præparater der omfatter polypeptider - Google Patents
Præparater der omfatter polypeptiderInfo
- Publication number
- DK1691833T3 DK1691833T3 DK04803302.1T DK04803302T DK1691833T3 DK 1691833 T3 DK1691833 T3 DK 1691833T3 DK 04803302 T DK04803302 T DK 04803302T DK 1691833 T3 DK1691833 T3 DK 1691833T3
- Authority
- DK
- Denmark
- Prior art keywords
- polypeptide
- binding sites
- polypeptides
- antigen binding
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03027511 | 2003-11-28 | ||
| PCT/EP2004/013445 WO2005052004A2 (en) | 2003-11-28 | 2004-11-26 | Compositions comprising polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1691833T3 true DK1691833T3 (da) | 2010-05-03 |
Family
ID=34626385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04803302.1T DK1691833T3 (da) | 2003-11-28 | 2004-11-26 | Præparater der omfatter polypeptider |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10000574B2 (da) |
| EP (2) | EP1691833B1 (da) |
| AT (1) | ATE459374T1 (da) |
| AU (1) | AU2004293182B2 (da) |
| BE (1) | BE2016C023I2 (da) |
| CA (1) | CA2544532C (da) |
| CY (2) | CY1110689T1 (da) |
| DE (1) | DE602004025840D1 (da) |
| DK (1) | DK1691833T3 (da) |
| ES (1) | ES2341252T3 (da) |
| HU (1) | HUS1600019I1 (da) |
| LU (1) | LU93067I2 (da) |
| NL (1) | NL300807I2 (da) |
| PL (1) | PL1691833T3 (da) |
| PT (1) | PT1691833E (da) |
| SI (1) | SI1691833T1 (da) |
| WO (1) | WO2005052004A2 (da) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2059536T1 (sl) | 2006-08-14 | 2014-06-30 | Xencor, Inc. | Optimirana protitelesa, ki ciljajo CD19 |
| KR101456728B1 (ko) | 2006-09-08 | 2014-10-31 | 메디뮨 엘엘씨 | 인간화 항-ｃｄ19 항체, 및 이것의 종양학, 이식 및 자가면역 질환의 치료에서의 용도 |
| EP2225275A4 (en) * | 2007-11-28 | 2013-04-03 | Medimmune Llc | PROTEIN FORMULATION |
| US8658765B2 (en) | 2009-12-31 | 2014-02-25 | Avidbiotics Corp. | Non-natural MIC proteins |
| US8796420B2 (en) | 2009-12-31 | 2014-08-05 | Avidbiotics Corp. | Non-natural MIC proteins |
| ES2563439T5 (es) | 2010-10-27 | 2022-02-04 | Amgen Res Munich Gmbh | Medios y métodos para tratar LDCBG |
| CN103561771B (zh) | 2011-03-17 | 2019-01-04 | 伯明翰大学 | 重新定向的免疫治疗 |
| CA2833019A1 (en) | 2011-04-22 | 2012-10-26 | Emergent Product Development Seattle, Llc | Prostate-specific membrane antigen binding proteins and related compositions and methods |
| GB201203442D0 (en) | 2012-02-28 | 2012-04-11 | Univ Birmingham | Immunotherapeutic molecules and uses |
| BR112016013741A2 (pt) | 2013-12-17 | 2017-10-03 | Genentech Inc | Usos de antagonistas de ligação de eixo de pd-1 e um anticorpo de anti-cd20, e kit compreendendo os mesmos |
| KR20240017102A (ko) | 2013-12-17 | 2024-02-06 | 제넨테크, 인크. | Pd-1 축 결합 길항제 및 탁산을 이용한 암 치료 방법 |
| EP3148580B1 (en) | 2014-05-29 | 2021-01-20 | MacroGenics, Inc. | Tri-specific binding molecules that specifically bind to multiple cancer antigens and methods of use thereof |
| AU2015342961B2 (en) | 2014-11-05 | 2021-08-12 | Genentech, Inc. | Methods of producing two chain proteins in bacteria |
| US10066002B2 (en) | 2014-11-05 | 2018-09-04 | Genentech, Inc. | Methods of producing two chain proteins in bacteria |
| CA2971288A1 (en) | 2015-02-02 | 2016-08-11 | The University Of Birmingham | Targeting moiety peptide epitope complexes having a plurality of t-cell epitopes |
| AU2016271142A1 (en) | 2015-05-29 | 2017-11-23 | Genentech, Inc. | PD-L1 promoter methylation in cancer |
| KR20180018538A (ko) | 2015-06-17 | 2018-02-21 | 제넨테크, 인크. | Pd-1 축 결합 길항제 및 탁산을 사용하여 국소적 진행성 또는 전이성 유방암을 치료하는 방법 |
| WO2017053469A2 (en) | 2015-09-21 | 2017-03-30 | Aptevo Research And Development Llc | Cd3 binding polypeptides |
| AR106188A1 (es) | 2015-10-01 | 2017-12-20 | Hoffmann La Roche | Anticuerpos anti-cd19 humano humanizados y métodos de utilización |
| CA3003482A1 (en) | 2015-11-19 | 2017-05-26 | Revitope Limited | Functional antibody fragment complementation for a two-components system for redirected killing of unwanted cells |
| EP3178848A1 (en) | 2015-12-09 | 2017-06-14 | F. Hoffmann-La Roche AG | Type ii anti-cd20 antibody for reducing formation of anti-drug antibodies |
| CN115920030A (zh) | 2015-12-09 | 2023-04-07 | 豪夫迈·罗氏有限公司 | Ii型抗cd20抗体用于降低抗药物抗体形成 |
| CA3006529A1 (en) | 2016-01-08 | 2017-07-13 | F. Hoffmann-La Roche Ag | Methods of treating cea-positive cancers using pd-1 axis binding antagonists and anti-cea/anti-cd3 bispecific antibodies |
| EP3252078A1 (en) | 2016-06-02 | 2017-12-06 | F. Hoffmann-La Roche AG | Type ii anti-cd20 antibody and anti-cd20/cd3 bispecific antibody for treatment of cancer |
| CN109963871A (zh) | 2016-08-05 | 2019-07-02 | 豪夫迈·罗氏有限公司 | 具有激动活性的多价及多表位抗体以及使用方法 |
| EP3497129A1 (en) | 2016-08-08 | 2019-06-19 | H. Hoffnabb-La Roche Ag | Therapeutic and diagnostic methods for cancer |
| TWI829628B (zh) | 2016-12-19 | 2024-01-21 | 瑞士商赫孚孟拉羅股份公司 | 與靶向4-1bb (cd137)促效劑併用之組合療法 |
| BR112019007267A2 (pt) | 2016-12-20 | 2019-07-09 | Hoffmann La Roche | anticorpo biespecífico anti-cd20/anti-cd3, produto farmacêutico, composição farmacêutica que compreende um anticorpo biespecífico anti-cd20/anti-cd3, uso de combinação de anticorpo biespecífico anti-cd20/anti-cd3 e um agonista de 4-1bb e método de tratamento ou retardamento da progressão de câncer em pacientes |
| MX2019014274A (es) | 2017-06-02 | 2020-01-23 | Hoffmann La Roche | Metodo de tratamiento. |
| KR20200084006A (ko) | 2017-11-01 | 2020-07-09 | 에프. 호프만-라 로슈 아게 | 표적화된 ox40 작용제를 사용하는 병용 요법 |
| CN111655731A (zh) | 2018-03-13 | 2020-09-11 | 豪夫迈·罗氏有限公司 | 用靶向性4-1bb(cd137)激动剂的组合疗法 |
| KR20200132913A (ko) | 2018-03-13 | 2020-11-25 | 에프. 호프만-라 로슈 아게 | 4-1bb 작용제와 항-cd20 항체의 치료 조합 |
| AU2019282836A1 (en) * | 2018-06-07 | 2021-01-07 | Cullinan Oncology, Inc. | Multi-specific binding proteins and methods of use thereof |
| CA3111809A1 (en) | 2018-09-21 | 2020-03-26 | Genentech, Inc. | Diagnostic methods for triple-negative breast cancer |
| CA3117051A1 (en) | 2018-11-05 | 2020-05-14 | Genentech, Inc. | Methods of producing two chain proteins in prokaryotic host cells |
| EP3962948A1 (en) | 2019-04-30 | 2022-03-09 | Amgen Research (Munich) GmbH | Means and methods of treating burkitt lymphoma or leukemia |
| JP7137696B2 (ja) | 2019-05-14 | 2022-09-14 | プロヴェンション・バイオ・インコーポレイテッド | １型糖尿病を予防するための方法および組成物 |
| WO2021257503A1 (en) | 2020-06-16 | 2021-12-23 | Genentech, Inc. | Methods and compositions for treating triple-negative breast cancer |
| KR102453073B1 (ko) | 2020-08-14 | 2022-10-11 | 건국대학교 글로컬산학협력단 | 피키아 파스토리스를 이용한 이중특이적 항체의 제조방법 및 이에 따른 이중특이적 항체 |
| JP2024505600A (ja) | 2021-02-03 | 2024-02-06 | モーツァルト セラピューティクス， インコーポレイテッド | 結合剤およびそれを使用する方法 |
| CN117279664A (zh) | 2021-04-10 | 2023-12-22 | 普方生物制药美国公司 | Folr1结合剂、其偶联物及其使用方法 |
| CN117203238A (zh) | 2021-04-23 | 2023-12-08 | 普方生物制药美国公司 | Cd70结合剂、其偶联物及其使用方法 |
| EP4083061A1 (en) * | 2021-04-30 | 2022-11-02 | Kilometro Rosso SPA | Fusion proteins and use thereof in the treatment of membranous nephropathy |
| KR20240005691A (ko) | 2021-04-30 | 2024-01-12 | 에프. 호프만-라 로슈 아게 | 항-cd20/항-cd3 이중특이적 항체 및 항-cd79b 항체 약물 접합체를 이용한 병용 치료를 위한 투약 |
| AU2021443863A1 (en) | 2021-04-30 | 2023-10-26 | F. Hoffmann-La Roche Ag | Dosing for treatment with anti-cd20/anti-cd3 bispecific antibody |
| TW202320857A (zh) | 2021-07-06 | 2023-06-01 | 美商普方生物製藥美國公司 | 連接子、藥物連接子及其結合物及其使用方法 |
| WO2023076876A1 (en) | 2021-10-26 | 2023-05-04 | Mozart Therapeutics, Inc. | Modulation of immune responses to viral vectors |
| US20230414750A1 (en) | 2022-03-23 | 2023-12-28 | Hoffmann-La Roche Inc. | Combination treatment of an anti-cd20/anti-cd3 bispecific antibody and chemotherapy |
| JP2024517042A (ja) | 2022-04-13 | 2024-04-19 | エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト | 抗ｃｄ２０／抗ｃｄ３二重特異性抗体の薬学的組成物及び使用方法 |
| WO2024030956A2 (en) | 2022-08-03 | 2024-02-08 | Mozart Therapeutics, Inc. | Cd39-specific binding agents and methods of using the same |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| JPH02500329A (ja) | 1987-05-21 | 1990-02-08 | クリエイテイブ・バイオマリキユールズ・インコーポレーテツド | ターゲット化多機能蛋白質 |
| US5258498A (en) | 1987-05-21 | 1993-11-02 | Creative Biomolecules, Inc. | Polypeptide linkers for production of biosynthetic proteins |
| US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| DK0573551T3 (da) | 1991-02-27 | 2003-08-04 | Micromet Ag | Serinrige peptidlinkere |
| US5525491A (en) | 1991-02-27 | 1996-06-11 | Creative Biomolecules, Inc. | Serine-rich peptide linkers |
| US5656730A (en) * | 1995-04-07 | 1997-08-12 | Enzon, Inc. | Stabilized monomeric protein compositions |
| JP4169478B2 (ja) * | 1998-04-21 | 2008-10-22 | マイクロメット アーゲー | Ｃｄ１９×ｃｄ３特異的ポリペプチドおよびその使用 |
| US20020142964A1 (en) * | 2000-11-02 | 2002-10-03 | Nissen Torben Lauesgaard | Single-chain polypeptides |
| KR100913714B1 (ko) * | 2001-11-08 | 2009-08-24 | 패시트 바이오테크 코포레이션 | Ｉｇｇ 항체의 안정한 액상 약학 제형물 |
-
2004
- 2004-11-26 DK DK04803302.1T patent/DK1691833T3/da active
- 2004-11-26 AU AU2004293182A patent/AU2004293182B2/en active Active
- 2004-11-26 EP EP04803302A patent/EP1691833B1/en active Active
- 2004-11-26 AT AT04803302T patent/ATE459374T1/de active
- 2004-11-26 ES ES04803302T patent/ES2341252T3/es active Active
- 2004-11-26 CA CA2544532A patent/CA2544532C/en active Active
- 2004-11-26 US US10/580,660 patent/US10000574B2/en active Active
- 2004-11-26 EP EP10155222A patent/EP2186527A1/en not_active Withdrawn
- 2004-11-26 PL PL04803302T patent/PL1691833T3/pl unknown
- 2004-11-26 PT PT04803302T patent/PT1691833E/pt unknown
- 2004-11-26 WO PCT/EP2004/013445 patent/WO2005052004A2/en active Application Filing
- 2004-11-26 DE DE602004025840T patent/DE602004025840D1/de active Active
- 2004-11-26 SI SI200431360T patent/SI1691833T1/sl unknown
-
2010
- 2010-05-27 CY CY20101100465T patent/CY1110689T1/el unknown
-
2016
- 2016-05-03 NL NL300807C patent/NL300807I2/nl unknown
- 2016-05-05 CY CY2016010C patent/CY2016010I2/el unknown
- 2016-05-05 HU HUS1600019C patent/HUS1600019I1/hu unknown
- 2016-05-10 BE BE2016C023C patent/BE2016C023I2/fr unknown
- 2016-05-11 LU LU93067C patent/LU93067I2/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2544532A1 (en) | 2005-06-09 |
| CY2016010I1 (el) | 2016-08-31 |
| LU93067I2 (fr) | 2016-07-11 |
| DE602004025840D1 (de) | 2010-04-15 |
| SI1691833T1 (sl) | 2010-06-30 |
| EP2186527A1 (en) | 2010-05-19 |
| PL1691833T3 (pl) | 2010-08-31 |
| ATE459374T1 (de) | 2010-03-15 |
| CA2544532C (en) | 2015-06-16 |
| US10000574B2 (en) | 2018-06-19 |
| CY2016010I2 (el) | 2016-08-31 |
| US20070249529A1 (en) | 2007-10-25 |
| AU2004293182B2 (en) | 2010-02-18 |
| WO2005052004A2 (en) | 2005-06-09 |
| HUS1600019I1 (hu) | 2016-06-28 |
| PT1691833E (pt) | 2010-06-08 |
| NL300807I2 (da) | 2016-10-13 |
| WO2005052004A3 (en) | 2006-03-09 |
| BE2016C023I2 (da) | 2023-12-18 |
| EP1691833B1 (en) | 2010-03-03 |
| AU2004293182A1 (en) | 2005-06-09 |
| EP1691833A2 (en) | 2006-08-23 |
| CY1110689T1 (el) | 2015-06-10 |
| ES2341252T3 (es) | 2010-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1600019I1 (hu) | Polipeptideket tartalmazó készítmények | |
| CY1118951T1 (el) | Χρηση αντισωματων υποδοχεα ιντερλευκινης-4 και συνθεσεις αυτων | |
| CY2019029I1 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις | |
| PL1639011T3 (pl) | Pegilowane przeciwciała jednodomenowe (dAb) | |
| ATE469176T1 (de) | Modifizierter anti-tnf antikörper | |
| CY1119291T1 (el) | Πολυσθενη αντισωματα και χρησεις για αυτα | |
| CY1112993T1 (el) | Παραγοντες ειδικης δεσμευσης της αγγειοποιητινης-2 και της αγγειοποιητινης-1 | |
| UA89017C2 (uk) | ЛЮДСЬКЕ АНТИТІЛО, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ЛЮДСЬКИМ TNFSF13b | |
| WO2003011895A8 (en) | Compositions and methods for modulation of immune responses | |
| CY1114851T1 (el) | Il-1βητα δεσμευτικα αντισωματα και θραυσματα αυτων | |
| CY2014038I1 (el) | Αντι-il-6 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
| DE60142342D1 (de) | Antikörper gegen doppelintegrinen, zusammensetzungen, verfahren und verwendungen | |
| SG166090A1 (en) | Il-13 binding agents | |
| NO20041325L (no) | Substanser | |
| ATE512986T1 (de) | Antikörper gegen clostridium difficile-toxine und ihre verwendung | |
| BRPI0406800B8 (pt) | "dímero de peptídeo, composição farmacêutica contendo o mesmo e seu uso | |
| WO2002036625A3 (en) | Prokineticin polypeptides, related compositions and methods | |
| EP1691664A4 (en) | ANTIBODIES AND / OR THEIR CONJUGATES BINDING TO THE AMINOTERMINAL FRAGMENT OF UROKINASE, COMPOSITIONS AND THEIR USES | |
| WO2002076406A3 (en) | Antibodies against autoantigens of primary biliary cirrhosis and methods of making and using them | |
| NO20033260D0 (no) | Materialer omfattende sykloheksamantan | |
| EA200400384A1 (ru) | Растворимый рецептор т-клетки |